INTS News - Candlesense

Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

SHELTON, Conn., Aug. 12, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and de...

Could this trigger changes in analyst coverage or rating adjustments? What is the market's perception of the company's financial stability after regaining compliance? Are there any pending regulatory or financial filings related to the equity compliance?

Compliance

12 days ago